Chronic optogenetic activation augments aβ pathology in a mouse model of Alzheimer disease

Cell Rep. 2015 May 12;11(6):859-865. doi: 10.1016/j.celrep.2015.04.017. Epub 2015 Apr 30.

Abstract

In vivo experimental evidence indicates that acute neuronal activation increases Aβ release from presynaptic terminals, whereas long-term effects of chronic synaptic activation on Aβ pathology remain unclear. To address this issue, we adopted optogenetics and transduced stabilized step-function opsin, a channelrhodopsin engineered to elicit a long-lasting neuronal hyperexcitability, into the hippocampal perforant pathway of APP transgenic mice. In vivo microdialysis revealed a ∼24% increase in the hippocampal interstitial fluid Aβ42 levels immediately after acute light activation. Five months of chronic optogenetic stimulation increased Aβ burden specifically in the projection area of the perforant pathway (i.e., outer molecular layer of the dentate gyrus) of the stimulated side by ∼2.5-fold compared with that in the contralateral side. Epileptic seizures were observed during the course of chronic stimulation, which might have partly contributed to the Aβ pathology. These findings implicate functional abnormalities of specific neuronal circuitry in Aβ pathology and Alzheimer disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology*
  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Dentate Gyrus / metabolism
  • Dentate Gyrus / pathology
  • Disease Models, Animal
  • Entorhinal Cortex / metabolism
  • Entorhinal Cortex / pathology
  • Mice, Transgenic
  • Neurons / metabolism
  • Neurons / pathology
  • Opsins / metabolism
  • Optogenetics / methods*
  • Perforant Pathway / metabolism
  • Perforant Pathway / pathology
  • Transduction, Genetic

Substances

  • Amyloid beta-Peptides
  • Opsins